← Markets

Aveanna Healthcare Holdings Inc.

AVAH · NASDAQ

Market closed$9.69$-0.210000 (-2.12%)After hours $9.69 · 0.00%

Key statistics

Previous close$9.90
Open$9.73
Day high$9.99
Day low$9.60
52-week high$10.32
52-week low$3.73
Market cap2.11B
Volume1.65M
Average volume1.95M
P/E ratio14.25
Forward P/E—
EPS0.68
Dividend yield0.00%

Market context

Why it moved

AVAH shares declined modestly amid broader market weakness driven by falling AI stocks and rising oil prices tied to an expanding U.S. military campaign against Iran, which weighed on investor sentiment despite an analyst report suggesting Aveanna Healthcare Holdings remains undervalued with strong long-term fundamentals.

BniajfiStockinvestAbc11NacwaRestaurantdive

What is happening

Recent company-specific developments and publisher coverage.

July 18, 2026Aveanna Healthcare shares declined amid broader healthcare sector pressure, even as multiple recent analyses highlight the stock as undervalued. A DCF model pegs intrinsic value near $13.86—roughly 43% above Thursday's close—while the P/E of ~8.2x sits far below the industry average of ~25x. Macro headwinds loom, as ACA subsidy rollbacks and Medicaid work requirements are squeezing enrollment across major insurers and hospital chains, raising concerns about reimbursement exposure for home care providers like Aveanna, which derives ~91% of revenue from Medicare and Medicaid.

-2.1212

July 17, 2026Aveanna Healthcare shares rallied on above-average volume, lifted by a broad healthcare sector tailwind after UnitedHealth Group's Q2 2026 earnings blowout — which showed a dramatically improved medical cost ratio and raised full-year guidance — boosted sentiment across home health and managed care names. Analyst coverage has highlighted Aveanna's compelling value profile, with Zacks assigning a #2 rank and an 'A' grade for Value, while a MarketBeat analyst noted the stock's 16% revenue growth, twice-raised guidance, and institutional capacity constraints as reasons retail investors may still have an edge despite a 120%+ one-year run.

3.125

July 16, 2026Aveanna Healthcare closed up nearly 3%, outperforming the broader healthcare sector (XLV ended little changed) as fresh analyst attention highlighted the home care provider's value profile. Zacks assigned AVAH a Rank #2 rating with an A grade for Value, and a MarketBeat feature flagged the stock as a potential buyout target given its ~$2 billion market cap, 16% revenue growth, and twice-raised guidance. Analysts note that a recent credit facility repricing—cutting interest margins by at least 50 basis points—should ease pressure from its $1.47 billion variable-rate debt load, bolstering the value case. Meanwhile, sector peers faced headwinds: HCA Healthcare cut its 2026 profit outlook citing a surge in uninsured patients, dragging hospital stocks lower and reinforcing the relative appeal of lower-cost home-based care models like Aveanna's.

2.7837

July 15, 2026Aveanna Healthcare closed down 3.41% during the regular session but is rebounding sharply in after-hours trading, rising over 3%, likely in response to Truist raising its price target on the home healthcare provider to $11 from $9 — though maintaining a Hold rating. Separately, Zacks assigned AVAH a Rank #2 Buy with an A grade for Value, highlighting the stock's attractive valuation metrics and a recent credit facility repricing that cut interest margins by at least 50 basis points, potentially easing pressure on its ~$1.47B variable-rate debt load. The broader healthcare sector (XLV) finished essentially flat, while sector peers faced headwinds from HCA Healthcare's Q2 profit warning tied to rising uninsured volumes.

-3.4126

July 10, 2026Aveanna Healthcare shares rose, outperforming the broader healthcare sector (XLV essentially flat in after-hours) as analysts and investors flagged the stock as a compelling value-momentum play amid geopolitical uncertainty. Barclays reiterated an Overweight rating and raised its price target to $9.50, while multiple analyst pieces highlighted AVAH as one of the cheapest medical stocks worth buying as US-Iran tensions drive demand for defensive healthcare names. The stock is also drawing momentum investor attention after Zacks featured it as a top momentum pick, with volume running above its 30-day average.

2.3983

July 8, 2026Aveanna Healthcare closed essentially flat amid a broader risk-off session triggered by escalating U.S.-Iran tensions, which sent oil prices surging over 5% and weighed on equities broadly. Despite the macro headwinds, the home health and hospice care name held its ground, supported by the healthcare sector's continued relative strength — XLV posted a 6.6% gain in June and healthcare has been the top-performing S&P 500 sector for two consecutive weeks. Weiss Ratings reiterated a Hold (C+) on the stock on July 2, while peer BrightSpring Health Services surged 43% post-Q1 earnings, reflecting strong investor appetite for well-executing home health operators ahead of Q2 reporting season.

-0.1042

July 7, 2026Aveanna Healthcare closed modestly higher on the regular session, gaining about 0.73%, though shares slipped roughly 2.7% in after-hours trade. The stock is riding a broader healthcare sector tailwind — XLV has surged over 13% in recent weeks, making healthcare the top-performing S&P 500 sector, buoyed by rotation out of tech. Zacks recently featured Aveanna as a notable stock pick, and the home health & hospice peer group has broadly outperformed since Q1 earnings, up ~9.8% on average, supported by aging population tailwinds and growing preference for in-home care.

0.7345

July 7, 2026Aveanna Healthcare Holdings surged nearly 5%, outperforming both the broader healthcare sector (XLV) and the S&P 500, with volume running well above average at nearly 3.1 million shares versus its ~1.8 million average. Momentum appears tied to Zacks featuring AVAH as a highlighted stock pick and a broader rally in home health & hospice peers — the subsector posted average share price gains of 9.8% since Q1 earnings, buoyed by tailwinds from an aging population and growing demand for in-home care. A late-June Seeking Alpha RSI watchlist also flagged AVAH as flashing overbought signals, suggesting heightened retail investor attention on the low-priced stock.

4.7253

The Globe and Mail · June 3, 2026Aveanna Healthcare Raises 2026 Guidance After Family First AcquisitionGlobeNewswire · June 2, 2026Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 GuidanceHome Health Care News · May 15, 2026Aveanna Expects ‘Zero Impact’ From Home Health MoratoriumSeeking Alpha · March 21, 2026Aveanna Healthcare Holdings: Recent Results Have Me More Optimistic (Rating Upgrade)
Mt Newswire · July 14, 2026Truist Raises Price Target on Aveanna Healthcare Holdings to $11 From $9, Keeps Hold Rating
Benzinga · July 9, 2026Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $9.5
Mt Newswire · June 5, 2026Aveanna Healthcare Holdings Insider Sold Shares Worth $43,680,000, According to a Recent SEC Filing
Mt Newswire · June 5, 2026Aveanna Healthcare Holdings Insider Sold Shares Worth $43,680,000, According to a Recent SEC Filing
Mt Newswire · June 3, 2026Aveanna Healthcare's Preferred Payor Relationships Buffer Medicaid Pressures, RBC Says
Mt Newswire · June 3, 2026RBC Upgrades Aveanna Healthcare Holdings to Outperform From Sector Perform, Keeps $10 Price Target
Benzinga · June 2, 2026Aveanna Raises Outlook After Family First Buy
Benzinga · June 2, 2026Aveanna Healthcare Hldgs Raises FY2026 Sales Guidance from $2.560B-$2.580B to $2.630B-$2.650B vs $2.559B Est

Peers

S&P 500SPX · $7,457.69-1.01%Addus HomeCare CorporationADUS · $114.52+0.62%The Pennant Group, Inc.PNTG · $41.95+0.58%Encompass Health CorporationEHC · $112.21-0.25%Chemed CorporationCHE · $510.03+1.70%Option Care Health, Inc.OPCH · $21.74-1.63%RadNet, Inc.RDNT · $62.19-1.27%Astrana Health, Inc.ASTH · $44.94-0.35%LifeStance Health Group, Inc.LFST · $11.58+2.57%U.S. Physical Therapy, Inc.USPH · $73.56-0.85%Pediatrix Medical Group, Inc.MD · $26.13-0.80%Sonida Senior Living, Inc.SNDA · $40.84+0.91%